Increased free water in the substantia nigra of Parkinson's disease: A single-site and multi-site study

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 1097-1104

  Ofori, Edward ^a   Pasternak, Ofer ^b   Planetta, Peggy J ^a   Burciu, Roxana ^a   Snyder, Amy ^a   Febo, Marcelo ^c   Golde, Todd E ^c   Okun, Michael S ^a   Vaillancourt, David E ^a,d  

^a UNIVERSITY OF FLORIDA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

Author keywords

Diffusion MRI; Free water mapping; Parkinson's disease; Substantia nigra

Indexed keywords

FREE WATER; UNCLASSIFIED DRUG; WATER;

ADULT; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; PARKINSON DISEASE; PUTAMEN; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION STUDY; VOXEL BASED MORPHOMETRY; WHITE MATTER; AGED; ANISOTROPY; BODY WATER; DIFFUSION WEIGHTED IMAGING; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ANISOTROPY; BODY WATER; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84922849237     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.10.029     Document Type: Article

References (49)

1. Alexander A.L., Hasan K.M., Lazar M., Tsuruda J.S., Parker D.L. Analysis of partial volume effects in diffusion-tensor MRI. Magn. Reson. Med. 2001, 45:770-780.
2. Barcia C., Bahillo A.S., Fernández-Villalba E., Bautista V., Poza Y., Poza M., Fernández-Barreiro A., Hirsch E.C., Herrero M.T. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 2004, 46:402-409.
3. Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J.Magn. Reson. B 1996, 111:209-219.
4. Behrens T.E., Woolrich M.W., Jenkinson M., Johansen-Berg H., Nunes R.G., Clare S., Matthews P.M., Brady J.M., Smith S.M. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn. Reson. Med. 2003, 50:1077-1088.
5. Berlot R., Metzler-Baddeley C., Jones D.K., O'Sullivan M.J. CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment. Neuroimage 2014, 92:27-35.
6. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
7. Chan L.L., Rumpel H., Yap K., Lee E., Loo H.V., Ho G.L., Fook-Chong S., Yuen Y., Tan E.K. Case-control study of diffusion tensor imaging in Parkinson's disease. J.Neurol. Neurosurg. Psychiatry 2007, 78:1383-1386.
8. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122(Pt 8):1437-1448.
9. Du G., Lewis M.M., Sen S., Wang J., Shaffer M.L., Styner M., Yang Q.X., Huang X. Imaging nigral pathology and clinical progression in Parkinson's disease. Mov. Disord. 2012, 27:1636-1643.
10. Du G., Lewis M.M., Styner M., Shaffer M.L., Sen S., Yang Q.X., Huang X. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov. Disord. 2011, 26:1627-1632.
11. Farooqui T., Farooqui A.A. Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis. 2011, 2011:247467.
12. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
13. Fonov V., Evans A.C., Botteron K., Almli C.R., McKinstry R.C., Collins D.L. Unbiased average age-appropriate atlases for pediatric studies. Neuroimage 2011, 54:313-327.
14. Gyoneva S., Shapiro L., Lazo C., Garnier-Amblard E., Smith Y., Miller G.W., Traynelis S.F. Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease. Neurobiol. Dis. 2014, 67:191-202.
15. Hess C.W., Ofori E., Akbar U., Okun M.S., Vaillancourt D.E. The evolving role of diffusion magnetic resonance imaging in movement disorders. Curr. Neurol. Neurosci. Rep. 2013, 13:400.
16. Hodaie M., Neimat J.S., Lozano A.M. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Neurosurgery 2007, 60:17-28. discussion 28-30.
17. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992. Neurology 2001, 57:S34-S38.
18. Kordower J.H., Olanow C.W., Dodiya H.B., Chu Y., Beach T.G., Adler C.H., Halliday G.M., Bartus R.T. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 2013, 136:2419-2431.
19. Lehéricy S., Sharman M.A., Santos C.L.D., Paquin R., Gallea C. Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov. Disord. 2012, 27:822-830.
20. Ma S.Y., Rinne J.O., Collan Y., Röyttä M., Rinne U.K. Aquantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease. J.Neurol. Sci. 1996, 140:40-45.
21. Maier-Hein K.H., Westin C.F., Shenton M.E., Weiner M.W., Raj A., Thomann P., Kikinis R., Stieltjes B., Pasternak O. Widespread white matter degeneration preceding the onset of dementia. Alzheimers Dement 2014, 10.1016/j.jalz.2014.04.518.
22. Menke R.A., Scholz J., Miller K.L., Deoni S., Jbabdi S., Matthews P.M., Zarei M. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009, 47:435-441.
23. Metzler-Baddeley C., O'Sullivan M.J., Bells S., Pasternak O., Jones D.K. How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage 2012, 59:1394-1403.
24. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 1994, 180:147-150.
25. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 1996, 211:13-16.
26. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 1994, 165:208-210.
27. Mounsey R.B., Teismann P. Chelators in the treatment of iron accumulation in Parkinson's disease. Int. J. Cell Biol. 2012, 2012:12.
28. Pasternak O., Koerte I.K., Bouix S., Fredman E., Sasaki T., Mayinger M., Helmer K.G., Johnson A.M., Holmes J.D., Forwell L.A., Skopelja E.N., Shenton M.E., Echlin P.S. Hockey Concussion Education Project, Part 2. Microstructural white matter alterations in acutely concussed ice hockey players: a longitudinal free-water MRI study. J.Neurosurg. 2014, 120:873-881.
29. Pasternak O., Sochen N., Gur Y., Intrator N., Assaf Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 2009, 62:717-730.
30. Pasternak O., Westin C.F., Bouix S., Seidman L.J., Goldstein J.M., Woo T.U.W., Petryshen T.L., Mesholam-Gately R.I., McCarley R.W., Kikinis R., Shenton M.E., Kubicki M. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J.Neurosci. 2012, 32:17365-17372.
31. Péran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., Celsis P., Rascol O., Démonet J.F., Stefani A., Pierantozzi M., Pontieri F.E., Caltagirone C., Spalletta G., Sabatini U. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133:3423-3433.
32. Pfefferbaum A., Sullivan E.V. Increased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn. Reson. Med. 2003, 49:953-961.
33. Pierpaoli, C., Jones, Derek K., 2004. Removing CSF contamination in brain DT-MRIs by using a two-compartment tensor model. In: Proceedings 12th Annual Meeting ISMRM, Kyoto.
34. Price S., Paviour D., Scahill R., Stevens J., Rossor M., Lees A., Fox N. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 2004, 23:663-669.
35. Prodoehl J., Li H., Planetta P.J., Goetz C.G., Shannon K.M., Tangonan R., Comella C.L., Simuni T., Zhou X.J., Leurgans S., Corcos D.M., Vaillancourt D.E. Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov. Disord. 2013, 28:1816-1822.
36. Prodoehl J., Planetta P.J., Kurani A.S., Comella C.L., Corcos D.M., Vaillancourt D.E. Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. JAMA Neurol. 2013, 70:100-106.
37. Radau P.E., Linke R., Slomka P.J., Tatsch K. Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism. J.Nucl. Med. 2000, 41:220-227.
38. Rolheiser T., Fulton H., Good K., Fisk J., McKelvey J.R., Scherfler C., Khan N., Leslie R., Robertson H. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. J.Neurol. 2011, 258:1254-1260.
39. Scherfler C., Esterhammer R., Nocker M., Mahlknecht P., Stockner H., Warwitz B., Spielberger S., Pinter B., Donnemiller E., Decristoforo C., Virgolini I., Schocke M., Poewe W., Seppi K. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease. Brain 2013, 136:3028-3037.
40. Schwarz S.T., Abaei M., Gontu V., Morgan P.S., Bajaj N., Auer D.P. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. 2013, 3:481-488.
41. Shigemoto Y., Matsuda H., Kamiya K., Maikusa N., Nakata Y., Ito K., Ota M., Matsunaga N., Sato N. Invivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM. Neuroimage Clin. 2013, 2:491-496.
42. Sutachan, J.J., Casas, Z., Albarracin, S.L., Robert, B., Ii, S., Samudio, I., Gonzalez, J., Morales, L., Barreto, G.E., 2012. Cellular and molecular mechanisms of antioxidants in Parkinson's disease.15.
43. Tessitore A., Amboni M., Cirillo G., Corbo D., Picillo M., Russo A., Vitale C., Santangelo G., Erro R., Cirillo M., Esposito F., Barone P., Tedeschi G. Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am. J. Neuroradiol. 2012, 33:1804-1809.
44. Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7:65-74.
45. Vaillancourt D.E., Spraker M.B., Prodoehl J., Abraham I., Corcos D.M., Zhou X.J., Comella C.L., Little D.M. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009, 72:1378-1384.
46. Vaillancourt D.E., Spraker M.B., Prodoehl J., Zhou X.J., Little D.M. Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging. Neurobiol. Aging 2012, 33:35-42.
47. Venkateshappa C., Harish G., Mythri R., Mahadevan A., Srinivas Bharath M.M., Shankar S.K. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease. Neurochem. Res. 2012, 37:358-369.
48. Wang Y., Wang Q., Haldar J.P., Yeh F.C., Xie M., Sun P., Tu T.W., Trinkaus K., Klein R.S., Cross A.H., Song S.K. Quantification of increased cellularity during inflammatory demyelination. Brain 2011, 134:3590-3601.
49. Zhan W., Kang G.A., Glass G.A., Zhang Y., Shirley C., Millin R., Possin K.L., Nezamzadeh M., Weiner M.W., Marks W.J., Schuff N. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov. Disord. 2012, 27:90-97.